J Clin Neurol.  2017 Oct;13(4):444-446. 10.3988/jcn.2017.13.4.444.

Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy

Affiliations
  • 1Department of Neurology, Hospital Comarcal de Melilla, Melilla, Spain. jesusromeroimbroda@me.com
  • 2Department of Ophthalmology, Hospital Comarcal de Melilla, Melilla, Spain.

Abstract

No abstract available.


MeSH Terms

Amyloid Neuropathies*
Amyloid*
Humans
Prealbumin*
Amyloid
Prealbumin

Figure

  • Fig. 1 The figure shows scores on (A) NIS-LL, (B) NQOL, (C) Karnofsky Performance Scale Index of functional impairment, (D) R-ODS score scales and (E) mBMI. mBMI: Body Mass Index modified by total protein, NIS-LL: Neuropathy Impairment Score-Lower Limbs, NQOL: Norfolk Quality of Life-Diabetic Neuropathy Questionnarire, R-ODS: Rasch-built Overall Disability Scale.


Reference

1. Hund E, Linke RP, Willig F, Grau A. Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment. Neurology. 2001; 56:431–435.
Article
2. Benson MD. Liver transplantation and transthyretin amyloidosis. Muscle Nerve. 2013; 47:157–162.
Article
3. Said G, Planté-Bordeneuve V. Familial amyloid polyneuropathy: a clinico-pathologic study. J Neurol Sci. 2009; 284:149–154.
4. Sekijima Y, Yazaki M, Oguchi K, Ezawa N, Yoshinaga T, Yamada M, et al. Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology. 2016; 87:773–781.
Article
5. Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology. 2010; 75:324–327.
Article
6. Coelho T, Maia LF, da Silva AM, Cruz MW, Planté-Bordeneuve V, Suhr OB, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol. 2013; 260:2802–2814.
Article
7. Sekijima Y. Transthyretin-type cerebral amyloid angiopathy: a serious complication in post-transplant patients with familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry. 2015; 86:124.
Article
8. Benson MD, Smith RA, Hung G, Kluve-Beckerman B, Showalter AD, Sloop KW, et al. Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment. Amyloid. 2010; 17:43–49.
Article
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr